Lorenzo Gerratana

32PUBLICATIONS
222CO-AUTHORS
Predictive and prognostic markersCancer diagnosisToxicology (incl. clinical toxicology)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Mar 11, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.

Carolina Reduzzi, Eleonora Nicolò, Lorenzo Gerratana

|Aug 25, 2025
Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.

Lorenzo Gerratana, Carolina Reduzzi, Yue Ren

|Aug 14, 2025
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity.

Andrew A Davis, Ellen Jaeger, Ian S Hagemann

|Mar 31, 2025
Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel.

Alessandra Narcisi, Vito Di Lernia, Maria Esposito

|Mar 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Wolfgang Janni, Thomas W P Friedl, Tracy C Yab

|Dec 18, 2024
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer.

Linda Cucciniello, Eva Blondeaux, Claudia Bighin

Pageof 6

Frequent Collaborators

12 joint publications

Fabio Puglisi

9 joint publications

Massimo Cristofanilli

9 joint publications

Carolina Reduzzi

6 joint publications

Ami Shah